Literature DB >> 33158479

TOPK mediates hypoxia-induced epithelial-mesenchymal transition and the invasion of nonsmall-cell lung cancer cells via the HIF-1α/snail axis.

Jung-Hwan Park1, Minho Moon1, Jong-Seok Kim2, Sang-Muk Oh3.   

Abstract

Hypoxia has been suggested to induce epithelial-mesenchymal transition (EMT) in various cancer types via the transcription factor hypoxia-inducible factor-1 alpha (HIF-1α). Here, we demonstrated that TOPK upregulates EMT and the invasion of H460 nonsmall-cell lung cancer cells through the induction of the HIF-1α/Snail axis and hypoxic signaling. The expression of endogenous TOPK, phosphorylated TOPK, HIF-1α and Snail was significantly increased upon hypoxia exposure, but TOPK depletion markedly abrogated the induced mRNA and protein levels of HIF-1α and Snail. Interestingly, TOPK knockdown restored the hypoxia-induced suppression of E-cadherin and diminished hypoxia-induced N-cadherin expression. In addition, Snail depletion suppressed hypoxia-induced N-cadherin expression, which was attenuated by TOPK knockdown. Moreover, knockdown of Snail decreased hypoxia-induced nonsmall-cell lung cancer cell migration and invasion, which were suppressed by TOPK depletion. In summary, we conclude that TOPK positively regulates HIF-1α expression through hypoxia signaling and thereby promotes Snail expression, leading to EMT and the invasion of nonsmall-cell lung cancer cells. These findings suggest that TOPK plays a critical role as a novel mediator of hypoxia signaling that regulates nonsmall-cell lung cancer development.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epithelial-mesenchymal transition; HIF-1α; Hypoxia; Invasion; TOPK

Mesh:

Substances:

Year:  2020        PMID: 33158479     DOI: 10.1016/j.bbrc.2020.10.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

2.  PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.

Authors:  Kejing Zhu; Xueting Cheng; Shuman Wang; Hong Zhang; Yu Zhang; Xiong Wang; Yonggang Chen; Jinhu Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-21       Impact factor: 5.555

3.  TOPK Affects Autophagy of Skin Squamous Cell Carcinoma by Regulating NF-KB Pathway through HDAC1.

Authors:  Juan Li; Zhi-Chao Zhang; Xiang-Shi Yuan; Shan-Shan Tang; Tao Wang; Hong-Fu Liu; Yu Cao
Journal:  Dis Markers       Date:  2022-06-15       Impact factor: 3.464

Review 4.  PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.

Authors:  Hai Huang; Mee-Hyun Lee; Kangdong Liu; Zigang Dong; Zeayoung Ryoo; Myoung Ok Kim
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.